Results 171 to 180 of about 4,243,211 (352)

Combining development, capacity building and responsible innovation in GCRF-funded medical technology research. [PDF]

Dev World Bioeth, 2022
Bezuidenhout L, Stirling J, Sanga VL, Nyakyi PT, Mwakajinga GA, Bowman R.   +5 more
europepmc   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Editorial: High-tech personalized healthcare in movement disorders

Frontiers in Neurology
Alessandro Zampogna, Alessandro Zampogna, Luigi Borzì, Carolina Soares, Carolina Soares, Florenc Demrozi   +5 more
doaj   +1 more source

Editorial: Data-Enabled Intelligence for Medical Technology Innovation, Volume I. [PDF]

Front Med Technol, 2021
Zeng N, Clawson K, Peng Y.
europepmc   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Ecology and Human Health: Medical Technology Aspects. [PDF]

Biomed Eng (NY), 2021
Severin AE, Sushkova LT, Batotsyrenova TE.   +2 more
europepmc   +1 more source

Information Technology and Medical Missteps: Evidence from a Randomized Trial [PDF]

We analyze the effect of a decision support tool designed to help physicians detect and correct medical "missteps". The data comes from a randomized trial of the technology on a population of commercial HMO patients.
James B. Rebitzer, Jonathan C. Javitt, Lonny Reisman   +2 more
core  

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Research and Technology Development for Delivering Practical Medical Application Using Human Pluripotent Stem Cells

, 2013
Norio Nakatsuji
openalex   +2 more sources

From medical devices to everyday products: exploring cross-cultural perceptions of assistive technology [PDF]

, 2019
Gabriella Spinelli, Massimo Micocci, Wendy Martin, Yuhan Wang   +3 more
openalex   +1 more source